We take a global view when it comes to our nutrition science engagement, providing scientific thought leadership to professional organizations. We are supporting global, trans-disciplinary research initiatives and advocacy. ADM’s team promotes cross-organization integration of nutrition initiatives, as well as designing and conducting a broad spectrum of nutrition research. Our research development expertise includes:
- Pre-clinical investigation
- Development of model systems
- Human clinical studies
Clinical trials for specific ADM health & wellness products are published in peer-reviewed journals. Our microbiome trials have been published in 59 industry publications. Our research capabilities include:
- Pre-clinical evaluation, including in vitro, cell cultures and C.elegans models
- Omics analysis, including genomics and metabolomics
- Microbiome analysis
- Strain development, including pilot, scale-up and stability
ADM has capabilities from sourcing and screening of novel strains, to preclinical and clinical evaluation, scale-up and industrial manufacturing of probiotics. We develop both proprietary strains and tailored formulations for our partners, and produce several tons of probiotics every year.
Novel Ingredient Development & Evaluation
We cover the whole process, from discovery all the way through to production. At ADM, we screen, select and isolate top strains using our C.elegans preclinical model, and perform genetic sequencing. Once identified, the strains are evaluated in vitro and in vivo following FAO/WHO guidelines.
ADM specializes in microbial strain and bioprocess design and development, including fermentation and downstream set-up and optimization. Our core expertise is the overproduction of valuable metabolites, such as proteins, specialized sugars and biopolymers.
Genomics & Sequencing
We utilize our unique massive genome sequencing capabilities, providing bioinformatics, biostatistics and advanced genomic- related analytics.